Clinical Trial Update: Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the safety and efficacy of repeat application of Picato 0.05% (ingenol mebutate) for treating anogenital warts. The results update the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anogenital Warts

Drugs mentioned

• Picato (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Anogenital Warts | Phase 2 | Status: COMPLETED